VF
BIB icon

Virtu Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Virtu Financial’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,676
Closed -$1.59M – 1429
2019
Q2 		$1.59M Buy
+30,676
New +$1.53M 0.09% 177
2019
Q1 		– Sell
-36,142
Closed -$1.52M – 1418
2018
Q4 		$1.52M Buy
+36,142
New +$1.89M 0.08% 177
2018
Q3 		– Sell
-20,311
Closed -$1.16M – 1551
2018
Q2 		$1.16M Buy
20,311
+13,262
+188% +$723K 0.07% 324
2018
Q1 		$388K Sell
7,049
-44,550
-86% -$2.67M 0.02% 858
2017
Q4 		$2.89M Buy
+51,599
New +$2.91M 0.15% 110
2017
Q1 		– Sell
-5,341
Closed -$213K – 409
2016
Q4 		$213K Buy
+5,341
New +$228K 0.02% 405
2016
Q3 		– Sell
-57,736
Closed -$2.24M – 368
2016
Q2 		$2.24M Sell
57,736
-51,777
-47% -$2.23M 0.3% 64
2016
Q1 		$4.48M Sell
109,513
-5,764
-5% -$255K 0.62% 33
2015
Q4 		$8.24M Buy
115,277
+59,744
+108% +$3.99M 1.17% 12
2015
Q3 		$3.24M Buy
+55,533
New +$4.73M 0.42% 52

Other funds holding BIB

CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CAL
Capital Analysts LLC Fort Washington, Pennsylvania $3.81B AUM 15.52% 1-Year Est. Return

Virtu Financial's BIB Position: Q3 2019 in Review

Virtu Financial sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2019, closing a stake of 30,676 shares — an estimated $1.59M sold.

Virtu Financial first reported a position in BIB in Q3 2015 and held it in 10 quarters. The position peaked at $8.24M in Q4 2015. 25 funds tracked by Wall St. Rank hold BIB as of Q3 2019.

  • Virtu Financial reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2019 after selling out during the quarter.
  • Virtu Financial sold 30,676 ProShares Ultra NASDAQ Biotechnology shares in Q3 2019, an estimated $1.59M.
  • Virtu Financial first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2015 and held it in 10 quarters.
  • Virtu Financial's ProShares Ultra NASDAQ Biotechnology position peaked at $8.24M in Q4 2015.
  • 25 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2019.

Based on Virtu Financial's 13F filing for Q3 2019, filed 20 Nov 2019.